Caladrius Biosciences Inc (NASDAQ:CLBS)

4.07
Delayed Data
As of Jun 15
 +0.02 / +0.49%
Today’s Change
2.63
Today|||52-Week Range
6.35
+15.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash19.2M20.3M14.7M34.2M
 
 
 
 
 
Short Term Investment Cash-27.0M1.1M-5.6M19.5M
 
 
 
 
 
Cash & Short Term Investments26.3M20.3M14.7M60.1M
 
 
 
 
 
 
ReceivablesReceivables3.1M2.6M2.9M234.5K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets4.3M3.5M3.5M790.5K
 
 
 
 
 
Current Assets33.7M26.4M21.1M61.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross21.4M24.6M25.6M1.1M
 
 
 
 
 
Depreciation-5.4M-7.5M-8.4M-832.4K
 
 
 
 
 
Intangible Assets72.8M9.9M9.3M--
 
 
 
 
Other Assets76.6M13.8M13.6M1.4M
 
 
 
 
 
Total Assets126.3M57.2M51.8M63.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.7M4.1M4.4M1.3M
 
 
 
 
 
Short Term Debt1.9M5.4M4.0M159.2K
 
 
 
 
 
Accrued Expenses1.5M3.4M1.9M4.0M
 
 
 
 
 
Other Current Liabilities5.8M8.8M7.0M6.4M
 
 
 
 
 
Other Liabilities16.2M21.0M19.5M9.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt14.7M11.4M2.8M0.00
 
 
 
 
Deferred Taxes-18.2M-932.7K-1.1M-575.1K
 
 
 
 
 
Other Liabilities804.5K562.0K389.9K0.00
 
 
 
 
Total Liabilities68.2M33.9M28.4M9.3M
 
 
 
 
 
 
EquityMinority Interest-593.3K-124.5K-653.2K-182.5K
 
 
 
 
 
Preferred Stock100.00100.0019.4M100.00
 
 
 
 
 
Common Equity58.5M23.7M4.9M50.5M
 
 
 
 
 
Total Shareholder Equity58.5M23.7M24.3M50.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding3.7M5.7M8.2M9.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.